The domestic medical device corporation Noeul announced on the 25th that it has signed a contract to supply an artificial intelligence (AI)-based malaria diagnostic solution miLab™ mol worth a total of $975,000 (approximately 1.36 billion won) to Ghana over the next two years.
Noeul plans to gradually supply this to major health institutions and malaria management hubs in Ghana through local partners. Ghana is one of the countries where malaria is a major infectious disease. It is estimated that there were about 6.55 million cases of malaria and approximately 11,000 deaths in Ghana in 2023.
miLab is an all-in-one AI digital microscope platform that performs the entire process from specimen pretreatment to high-resolution image capture, AI analysis, and result verification with a single compact device. This enables more accurate and efficient diagnostics.
In collaborative research with Labcorp, the largest diagnostic laboratory chain in the U.S., it recorded 100% in sensitivity, specificity, and positive and negative predictive values, demonstrating superior performance compared to standard microscopes. A report from UNITAID under the World Health Organization (WHO) has introduced it as 'the most advanced form of digital microscope platform integrating all functions of microscopic diagnosis.'
Im Chan-yang, the CEO, said, 'In West Africa, which accounts for one-third of global malaria, the growth momentum is increasing through public procurement and various partnerships.' He added, 'Having established a solid position in the African market, we will accelerate our expansion into overseas markets, including Europe and the United States, while continuously implementing value enhancement.'